Table 3.
Resources
| Source | Link | Description |
|---|---|---|
| Canadian HIV pregnancy planning guidelines (2012) |
http://www.jogc.com/article/S1701-2163(16)35274-4/pdf
http://www.ncbi.nlm.nih.gov/pubmed/23125998 |
Comprehensive safer conception guidelines |
| South African National contraception and fertility planning policy and service delivery guidelines (2012) |
http://www.doh.gov.za/docs/policy/2013/contraception_fertility_planning.pdf
https://www.health-e.org.za/wp-content/uploads/2014/05/ContraceptionPolicyServiceDelGuidelines2013.pdf |
Safer conception guidelines for South Africa (preceding approval of PrEP in SA) |
| U.S. DHHS Guidelines, Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, | http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf | Safer conception methods for HIV-serodiscordant couples are mentioned |
| ASRM guidelines on offering assisted reproductive technologies to HIV-affected individuals and couples |
https://www.asrm.org/uploadedFiles/ASRM_Content/News_and_Publications/Ethics_Committee_Reports_and_Statements/hivethics.pdf
http://www.reproductivefacts.org/globalassets/asrm/asrm-content/newsand-publications/ethics-committee-opinions/human_immunodeficiency_virus_and_infertility_treatment-pdfmembers.pdf |
Ethics Committee of the American Society for Reproductive Medicine, statement on the safety and ethics of offering assisted reproductive technologies to men and women living with and/or affected by HIV |
| WHO, Guidelines for use of antiretrovirals (2015) | http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/ | Guidelines re. the use of antiretrovirals as treatment and prevention |
| HIVE | https://www.hiveonline.org/ | Client-centered website committed to advancing reproductive and sexual wellness for individuals, families and communities affected by HIV in San Francisco and beyond |
| GlobalShare Listserv | https://www.hiveonline.org/resources/global-share/ | GlobalSHARE Google Group is an easily accessible venue to ask and answer important clinical questions, connect individuals to care, share protocols and tools, circulate important papers and presentations, advertise educational and funding opportunities, and create a space to recognize important work being done in the area of safer conception in the context of HIV |